Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859713 · ClinicalTrials.gov registry record · NA
Optimize Low Back Pain
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 749
- Enrollment target
NCT03859713: Completed NA study, sponsored by University of Utah.
NCT03859713 is a NA study that has completed, run by University of Utah. The registered enrollment target is 749 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03859713, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 749 participants
- Enrollment target
Study Summary
The objective of this study is to improve health care for patients with chronic LBP and increase the likelihood that patients obtain outcomes that matter most to them. The investigators will accomplish our goal using a sequential multiple randomization (SMART) design comparing the effectiveness of Phase 1 (PT v. CBT) treatments for patients with chronic LBP; and among patient non-responsive to Phase I treatment, compare the effectiveness of Phase II treatments (switching to PT or CBT v. mindfulness). Effectiveness will be based on patient-centered outcomes. Sub-aims will compare main effects of Phase 1 and 2 treatment options and the sequencing effects of different treatment combinations.
Primary Outcome
Back pain specific measure of functional disability to address Aim 1, score range 0-100 with neagtive values representing improvement in disability
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Mindfulness
- BEHAVIORAL Physical Therapy
- BEHAVIORAL Phase I Treatment
- BEHAVIORAL Phase II Switching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 749 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
What the finished NCT03859713 record still lists
NCT03859713 is an interventional study that assigns participants to a tested intervention. The registered 749 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 5 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT03859713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03859713 about?
NCT03859713 is a clinical study titled "Optimize Low Back Pain". The objective of this study is to improve health care for patients with chronic LBP and increase the likelihood that patients obtain outcomes that matter most to them. The investigators will accomplish our goal using a sequential multiple randomization (SMART) design comparing the effectiveness of P...
What is the current status of trial NCT03859713?
This trial is currently completed. It is a NA study. The enrollment target is 749 participants. The study started on 2019-03-22. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT03859713?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Mindfulness (BEHAVIORAL), Physical Therapy (BEHAVIORAL), Phase I Treatment (BEHAVIORAL), Phase II Switching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03859713?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03859713's enrollment target sits among peer trials
749 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI